APA (7th ed.) Citation

X, X., AE, M., X, Z., KG, L., CR, F., J, Z., . . . PY, S. (2021). Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19. Nature communications, 12(1), 3984. https://doi.org/10.1038/s41467-021-24300-8

Chicago Style (17th ed.) Citation

X, Xie, et al. "Author Correction: A Nanoluciferase SARS-CoV-2 for Rapid Neutralization Testing and Screening of Anti-infective Drugs for COVID-19." Nature Communications 12, no. 1 (2021): 3984. https://doi.org/10.1038/s41467-021-24300-8.

MLA (9th ed.) Citation

X, Xie, et al. "Author Correction: A Nanoluciferase SARS-CoV-2 for Rapid Neutralization Testing and Screening of Anti-infective Drugs for COVID-19." Nature Communications, vol. 12, no. 1, 2021, p. 3984, https://doi.org/10.1038/s41467-021-24300-8.